Cholesterol Self-testing in Patients Post Acute Coronary Syndrome

Summary

The pharmacological reduction of LDL-C lowers cardiovascular risk and is therefore a priority in cardiovascular secondary prevention. The achievement of LDL-C target levels in Germany, Europe, and worldwide is inadequate, despite a wide array of lipid-lowering medications. Only a small proportion of post-myocardial infarction patients reach their LDL-C target range within a year. There is a significant need for new strategies to improve LDL-C target achievement and thereby reduce the occurrence of secondary cardiovascular events. The aim of the study is to establish a basis for improving prevention by achieving the target LDL level effectively and quickly in patients with high and very high cardiovascular risk profiles.

Eligibility

Inclusion Criteria:

* Age ≥ 18 years
* Patients with acute coronary syndrome in the last 6 months and not having reached the LDL target value
* Signed informed consent

Exclusion Criteria:

* Persons unable to understand the study
* Persons unable or unwilling to perform self-measurements
* Persons unable or unwilling to undergo additional cholesterol-lowering therapy to reach the LDL target
* Pre-menopausal women without contraception
* Use of experimental drugs or investigational products within 30 days prior to screening
* Employees or contractors of the institution conducting the study or family members of the Principal Investigator, Co-Investigator, or financial supporter

Conditions5

Browse More Trials